Loading the session
Loading the session
Loading instrument
$127.42
+0.00%Delayed · Pre-marketDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 15:56 IST · A quote does not mean the product is available to trade on your account.
Opens 8:00 pm IST
Opens 8:00 pm IST
Opens 8:00 pm IST
In brief
Questions investors ask
Quotes run fifteen minutes behind.
Closed at $127.42 on 4 Nov 2026: 1.1% below the 52-week high of $128.83 (4 Nov 2026) and 149.8% above the low of $51.00 (8 May 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
1 month: +23.1% (SPY −1.6%, XLV +13.5%). 3 months: +52.4% (SPY −0.4%, XLV +15.5%). 1 year: +152.9% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: HAE, SPY and XLV · as of 4 Nov 2026
The 4 Nov 2026 close of $127.42 was 15.0% above its 50-day average ($110.82) and 60.5% above its 200-day average ($79.39). It has closed above the 200-day for 115 sessions, since 22 May 2026. The 50-day average crossed above the 200-day on 24 Jun 2026, 93 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
The 14-session relative strength index closed at 75.2 on 4 Nov 2026, its 1st session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.
Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026
3.4M shares were sold short at the 15 Oct 2026 settlement, 7.5% of the 45.5M shares outstanding; covering them would take 3.9 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Price return, split-adjusted
At the 4 Nov 2026 close
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.
October 8, 2026
+17.46%November 6, 2025
+32.31%August 7, 2025
−26.58%